Skip to content

Clinical trials

Fatty Liver trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: United Kingdom Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20113
20121
20151
20162
20173
20183
20192
20203
20213
20222
20233
20245
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting11
Unknown status6
Terminated5
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Oxford5
Imperial College London3
89bio, Inc.2
King's College Hospital NHS Trust2
Novo Nordisk A/S2
Sanofi2
Alnylam Pharmaceuticals1
AstraZeneca1
Axcella Health, Inc1
Bruce A. Griffin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver41
Non-alcoholic Fatty Liver Disease22
Fibrosis6
Liver Cirrhosis6
Liver Diseases6
Obesity6
Diabetes Mellitus, Type 25
Metabolic Diseases5
Diabetes Mellitus4
Digestive System Diseases4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.